Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Slides:

Advertisements

Similar presentations

Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study Evgenij V Potapov, MD, Heinz R Zurbrügg,

Advertisements

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

The Myocardial Protective Effects of a Moderate-Potassium Blood Cardioplegia in Pediatric Cardiac Surgery: A Randomized Controlled Trial Yang Liu, MD,

Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences Jean Deslauriers, MD, Jocelyn Grégoire,

A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients Lena Lindholm,

Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study Song Wan, MD, PhD, Jean-Louis.

Conservative treatment for postintubation tracheobronchial rupture

P. W. Boonstra, MD, PhD, Y. J. Gu, MD, PhD, C. Akkerman, BSc, J

Management of catheter-induced pulmonary artery perforation: a rare complication in cardiovascular operations Srikrishna Sirivella, MD, Isaac Gielchinsky,

Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants Takaaki Suzuki, MD, Toyoki Fukuda, MD, Tsutomu Ito, MD,

James L Zellner, MD, Scott B Kribbs, BS, B

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Prevalence of Heparin/Platelet Factor 4 Antibodies Before and After Cardiac Surgery Brendan M. Everett, MD, Robert Yeh, MD, Shi Yin Foo, MD, PhD, David.

Assessment of heparin anticoagulation: comparison of two commercially available methods Hanne I Flom-Halvorsen, PhD, Eivind Øvrum, MD, PhD, Michel Abdelnoor,

What is the marginal cost for marginal risk in cardiac surgery?

Steven R. Gundry, MD, Matthew A. Romano, MD, O

Current determinants of operative mortality in 1400 patients requiring aortic valve replacement Ines Florath, PhD, Ulrich P Rosendahl, MD, Amir Mortasawi,

Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only Thierry P Carrel, MD, Mike Schwanda, MD,

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all David Faraoni, MD,

Pleural Metastasis of Osteosarcoma

Ricardo H Boks, BS, Lex A van Herwerden, MD, PhD, Johanna J

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Heparin-induced thrombocytopenia and cardiac surgery

Anne H Kuitunen, MD, Lasse J Heikkilä, MD, Markku T Salmenperä, MD

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

Pediatric open heart operations without diagnostic cardiac catheterization Jean-Pierre Pfammatter, MD, Pascal A Berdat, MD, Thierry P Carrel, MD, Franco.

Wrapping Procedure for Stanford Type A Acute Aortic Dissection: Is There an Indication for Surgery Without a Cardiopulmonary Bypass? Stéphane Lopez,

Esophageal perforation by echoprobe during cardiac surgery: treatment by endoscopic stenting Albert M Nana, MD, Constantin Stefanidis, MD, Jean-Pierre.

Support Your Specialty

Benjamin C. Sun, MD, Timothy A. Dickinson, CCP, Eric A

Michel Carrier, MD, Michel Pellerin, MD, Louis P Perrault, MD, PhD, B

Michael J. Wolf, MD, Kirk R. Kanter, MD, Paul M. Kirshbom, MD, Brian E

Editorial Board, January 2010

Bradford B. Smith, MD, Matthew A

Assessment of spontaneous pneumomediastinum: experience with 12 patients Jacques B Jougon, MD, FETCS,, Michel Ballester, MD, PhD, Frédéric Delcambre,

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Individualized heparin and protamine management in infants and children undergoing cardiac operations Massimiliano Codispoti, MD, Christopher A Ludlam,

The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations Kojiro Furukawa, MDa, Hitoshi Ohteki, MDa, Kenji Hirahara,

The Annals of Thoracic Surgery

Transesophageal echocardiography-guided chordal replacement for tricuspid regurgitation Christophe Baufreton, MD, PhD, Jacques Laporte, MD, Jacques Langlais,

Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery Barbara A Konkle, MD, Thomas L Bauer, MD, Gowthami.

Long-Term Results of Thoracoscopic Sympathectomy for Hyperhidrosis

No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits Christian Olsson, MD, Agneta Siegbahn, MD, PhD,

Off-Pump Coronary Artery Bypass Disproportionately Benefits High-Risk Patients John D. Puskas, MD, Vinod H. Thourani, MD, Patrick Kilgo, MS, William Cooper,

Two Consecutive Open Heart Operations in a Small Child With Heparin-Induced Thrombocytopenia Type II Using Anticoagulation With Heparin and Tirofiban

Stephanie B. Clayton, PharmD, Jeffrey R. Acsell, CCP, Arthur J

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Neurocognitive Function and Cerebral Emboli: Randomized Study of On-Pump Versus Off-Pump Coronary Artery Bypass Surgery Reza Motallebzadeh, MRCS, J.

Preoperative Intraaortic Balloon Pump Enhances Cardiac Performance and Improves the Outcome of Redo CABG Jan T. Christenson, MD, PhD, Pierre Badel, MD,

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

Qing-yu Wu, MD The Annals of Thoracic Surgery

The future of cardiac surgery training: A survival guide

Neal S Goldstein, MD The Annals of Thoracic Surgery

Fraser D. Rubens, MD, MS, Gilbert Lavalee, Marc A

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Factors influencing intensive care unit length of stay after surgery for acute aortic dissection type A Daniel Hoefer, MD, Elfriede Ruttmann, MD, Markus.

Sunjay Kaushal, MD, PhD, Brody Wehman, MD

Increased neutrophil priming and sensitization before commencing cardiopulmonary bypass in cardiac surgical patients Y.John Gu, MD, PhD, Pieter Schoen,

Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions Ruth L Taylor, MSc, Michael A Borger, MD, Richard.

An Assay to Monitor Bivalirudin Levels on Cardiopulmonary Bypass

The Impact of New Technology on Cardiothoracic Surgical Practice

Robert J Frumento, MS, MPH, Catherine M

Safety of low hematocrits during cardiopulmonary bypass

Recombinant hirudin for extended aortic surgery in patients with heparin-induced thrombocytopenia Matthias Bauer, MD, Andreas Koster, MD, Miralem Pasic,

A randomized trial of antithrombin concentrate for treatment of heparin resistance Mathew R Williams, MD, Alyssa B D’Ambra, BA, James R Beck, Talia B.

Thrombophilic Variables Do Not Increase the Generation or Procoagulant Activity of Thrombin During Cardiopulmonary Bypass Peter Raivio, MD, Jari Petäjä,

Presentation transcript:

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent Piriou, MD, PhD, Olivier H Bastien, MD, Patrick Ffrench, MD, Michel Hanss, MD, Jean- Jacques Lehot, MD, PhD The Annals of Thoracic Surgery Volume 71, Issue 2, Pages 678-683 (February 2001) DOI: 10.1016/S0003-4975(00)02022-1

Fig 1 Algorithm for anticoagulation management in patients with HIT type II scheduled for cardiac surgery with CPB. (CPB = cardiopulmonary bypass; HIT = heparin-induced thrombocytopenia.) The Annals of Thoracic Surgery 2001 71, 678-683DOI: (10.1016/S0003-4975(00)02022-1)